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Digital  PCR  has  become  the  emerging  technique  for the  sequence-speciﬁc  detection  and  quantiﬁcation
of  nucleic  acids  for  various  applications.  During  the past years,  numerous  reports  on  the  development
of  new  digital  PCR methods  have  been  published.  Maturation  of these  developments  into  reliable  ana-
lytical  methods  suitable  for diagnostic  or other  routine  testing  purposes  requires  their  validation  for  the
intended  use.
Here,  the  results  of  an  in-house  validation  of  a droplet  digital  PCR  method  are  presented.  This  method
is  intended  for  the quantiﬁcation  of  the  absolute  copy  number  concentration  of a puriﬁed  linearizedigital PCR
ethod validation
easurement uncertainty
ertiﬁed reference materials
plasmid  in solution  with  a nucleic  acid background.  It has  been  investigated  which  factors  within  the
measurement  process  have  a signiﬁcant  effect  on  the measurement  results,  and  the  contribution  to  the
overall  measurement  uncertainty  has been  estimated.  A comprehensive  overview  is provided  on  all  the
aspects that  should  be  investigated  when  performing  an  in-house  method  validation  of  a  digital  PCR
method.
© 2016  The  Authors.  Published  by Elsevier  GmbH.  This  is an  open  access  article  under  the  CC  BY. Introduction
Accurate quantiﬁcation of the copy number concentration of
peciﬁc nucleic acid sequences is important for several applications
oth within the ﬁelds of red biotechnology, (e.g. oncology and infec-
ious diseases) and green biotechnology (e.g. GMO  testing). During
he last decade, digital PCR (dPCR) has shown to be the emerging
echnique for the sequence-speciﬁc detection and quantiﬁcation
f nucleic acids [1,2]. The measurement principle of dPCR relies on
artitioning the PCR mix  across a large number of small individual
eaction volumes, such that the distribution of the target sequence
ollows a binominal distribution function and that a part of the
eaction volumes does not contain a copy of the target sequence
3]. Following an end-point PCR, partitions containing one or more
opies of the target sequence are labelled positive and counted. The
roportion of positive partitions is used to estimate the copy num-
er concentration of the target sequence, taking into account the
tatistics of the binominal distribution [4]. Commercially available
PCR systems are based on two different approaches to partition
he PCR mix: some use microﬂuidic chips on which the PCR mix  is
∗ Corresponding author.
E-mail address: Liesbet.deprez@ec.europa.eu (L. Deprez).
ttp://dx.doi.org/10.1016/j.bdq.2016.08.002
214-7535/© 2016 The Authors. Published by Elsevier GmbH. This is an open access articlicense  (http://creativecommons.org/licenses/by/4.0/).
distributed over premanufactured chambers [5,6] while others are
based on oil-water emulsions to separate the solution into droplets
[7,8].
Digital PCR has the potential to replace quantitative real-time
PCR (qPCR) for several of the current applications as it can have
several advantages, including improved precision [9], reduced
interference of PCR inhibitors [10] and independence of a cali-
bration curve to determine the copy number concentration of the
target sequence [11]. However, the measurement principle of the
dPCR implies some essential prerequisites and failure to fulﬁl one or
more of these, affects the reliability of the measured absolute copy
number concentrations. First, the copies of the target sequence
should be distributed over the partitions in a random and uni-
form manner meaning that there should be no aggregation of DNA
sequences. Second, the volume of the partitions should be well-
known and consistent within and between measurements. Third,
partitions should be correctly classiﬁed as positive or negative after
the end-point PCR [12].
Numerous reports on the development of new dPCR methods
have been published during the past years. Maturation of these new
developments into reliable analytical methods suitable for diag-
nostic or other routine testing purposes requires that the methods
are validated for their intended use. Method validation is the tool
to proof that a method is ﬁt for purpose and to ensure that the
le under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Table  1
Critical performance characteristics which should be assessed during the validation
of a quantitative analytical method.
Performance characteristic Description
Selectivity Degree to which the method can
quantify the particular analyte (i.e. a
speciﬁc target sequence) accurately in
the presence of interfering substances
which could be present in the samples.
Working range The analyte concentration interval over
which the method provides results
with an acceptable uncertainty. In this
concentration range, the relationship
between response and concentration is
continuous, reproducible and linear
after suitable data transformation.
Accuracy The closeness of agreement between a
measurement result produced by the
method for the analyte in a certain
sample and the accepted reference
value of that analyte. Accuracy can be
divided into two  parts:
•  Precision Measure of the variability in
independent measurement results
obtained for the same sample under
stipulated conditions. There are three
different levels depending on the
conditions: repeatability, intermediate
precision and reproducibility.
•  Trueness The closeness of agreement between
the mean of an inﬁnite number of
measurement results produced by the
method for the analyte in a certain
sample and the accepted reference
value of that analyte.
Measurement uncertainty Interval associated with a
measurement result which expresses
the range of values that can reasonably
be attributed to the analyte being
measured.
Limit of detection (LOD) The lowest analyte concentration that
can be distinguished from zero, with a
speciﬁed level of conﬁdence.
Limit of quantiﬁcation (LOQ) The lowest analyte concentration for
which the method provides results
with an acceptable uncertainty.
Robustness (or ruggedness) Measure of the capacity of the method
to  remain unaffected by small, but
deliberate variations in method
parameters.
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a semi-skirted and PCR clean 96-well PCR plate (Eppendorf, cat no.he descriptions given in this table are based on the deﬁnitions and explanations as
rovided in several guidance documents [15–17].
easurement results are sufﬁciently reliable so that related deci-
ions can be taken with conﬁdence. International standards such
s ISO/IEC 17025 [13] and ISO 15189 [14] also stress the need
or method validation. There are several guidance documents on
ethod validation [15–17] describing a series of tests that both ver-
fy the assumptions on which the analytical method is based and
stablish the performance characteristics of the method. Table 1
rovides a list of performance characteristics that are typically
ssessed during method validation. Several of these performance
haracteristics are also included in the guidelines on Minimum
nformation for the publication of Quantitative dPCR Experiments
dMIQE) [18].
Here, a complete in-house validation is described for a dPCR
ethod using the droplet digitalTM PCR (ddPCR) system (Bio-Rad)
hich partitions the PCR mix  in approximately 20,000 droplets
ith an individual volume < 1 nL. This ddPCR method ampliﬁes a
peciﬁc sequence of the human fusion transcript BCR-ABL and is
ntended to be used for the quantiﬁcation of the absolute copy
umber concentration of a linearized plasmid carrying the BCR-
BL sequence in solution with a nucleic acid background. Thend Quantiﬁcation 9 (2016) 29–39
approaches for method validation described in the following can
be used as an example for the validation of other dPCR methods.
2. Materials and methods
2.1. Test material
The method validation was  performed on samples of certiﬁed
reference materials from the ERM-AD623 set [19]. ERM-AD623
consists of 6 solutions of a double-stranded linearized plasmid
carrying 3 DNA fragments speciﬁc for 3 human cDNA transcripts:
the transcript of the breakpoint cluster region gene (BCR), the
transcript of the glucuronidase beta gene (GUSB) and the aberrant
transcript (BCR-ABL b3a2) consisting of a fusion of the BCR gene
with the c-abl oncogene 1 (ABL). Each of the six solutions; ERM-
AD623a, ERM-AD623b, ERM-AD623c, ERM-AD623d, ERM-AD623e
and ERM-AD623f has a different certiﬁed copy number con-
centration: (1.08 × 106 ± 0.13 × 106), (1.08 × 105 ± 0.11 × 105),
(1.03 × 104 ± 0.10 × 104), (1.02 × 103 ± 0.09 × 103),
(1.04 × 102 ± 0.10 × 102) and (10.0 ± 1.5) copies(cp)/L, respec-
tively. The plasmid solutions were prepared in a T1E0.01 buffer
(1 mM Tris, 0.01 mM EDTA, pH 8.0) supplemented with 50 mg/L
of transfer RNA from Escherichia coli (E. coli). The certiﬁed copy
number concentrations and the associated uncertainties assigned
to the ERM-AD623 solutions were derived from measurement
data of 3 metrology institutes using a chip-based dPCR technology
(i.e. the BioMarkTM system with 12.765 digital Arrays TM from
Fluidigm).
2.2. ddPCR method
The ddPCR method validated in this study targets a sequence
speciﬁc for the human BCR-ABL transcript (referred here as the
BCR-ABL ddPCR method). Also, a second ddPCR method was  applied
targeting a sequence speciﬁc for the ABL transcript (called the ABL
ddPCR method). These ddPCR methods are based on two qPCR
methods which were developed within the frame of a ‘Europe
Against Cancer’ program [20,21]. The sequences of the primers
and probes and their concentrations used in the ddPCR methods
can be found in Supplementary data Table 1. The term ‘assay’ is
used to refer to the combination of the speciﬁc primers and probes.
All primers and probes were puriﬁed by HPLC (Life Technologies
Europe BV). The PCR mix  comprised 1 × ddPCR Supermix for Probes
(Bio-Rad, cat no. 186-3010), suitable primers and probes, nucle-
ase free water (Promega, cat no. P1193) and the DNA sample. To
minimise the uncertainty from pipetting, all components, exclud-
ing the DNA sample, were premixed in the pre-sample mix, and
the ﬁnal PCR mix  was prepared gravimetrically by combining the
DNA sample with the pre-sample mix  using a microbalance. The
density of the pre-sample mix  was  determined by pipetting 100 L
on the microbalance using a calibrated pipette. The average den-
sity and the associated standard deviation (STD) of 10 replicate
measurements were 1.0353 ± 0.0026 g/L.
Twenty microliters of the PCR mix  were pipetted into the com-
partments of the Droplet Generator DG8TM Cartridge (Bio-Rad, 2
types were used: cat no. 186-3008 and 186-4008) and 70 L of
the Droplet Generation Oil for Probes (Bio-Rad, cat no. 186-3005)
was added to the appropriate wells. The cartridges were covered
with DG8TM Gaskets (Bio-Rad, cat no. 186-3009) and placed in a
QX100TM Droplet Generator (Bio-Rad, cat no. 186-3002) to gener-
ate the droplets. Afterwards, the droplets were gently transferred to0030 128.605) using a Pipet-lite TMXLS+ manual 8-channel pipette
with the range 5–50 L (Rainin, cat no. L8-50XLS+). The PCR plate
was sealed with pierceable foil (Bio-Rad, cat no. 181-4040) using
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 PX1TM PCR Plate Sealer (Bio-Rad, cat no. 181-4000). After seal-
ng, the PCR plate was placed in a C1000 TouchTM Thermal Cycler
Bio-Rad, cat no. 185-1197) for PCR ampliﬁcation. The PCR proto-
ol can be found in the Supplementary data Table 2. The droplet
eading was done with the QX 100 Droplet reader (Bio-Rad, cat
o. 186-3001) using ddPCRTM Droplet Reader Oil (Bio-Rad, cat no.
86-3004).
.3. Data analysis
Data acquisition and analysis were performed with the software
ackage QuantaSoft (Bio-Rad). As measurements were spread over
n extended period, three different versions of this software were
sed: version 1.3.2.0, version 1.6 and version 1.7.4. The ﬂuores-
ence amplitude threshold, distinguishing the positive from the
egative droplets was set manually by the analyst as the midpoint
etween the average ﬂuorescence amplitude of the positive and
egative droplet cluster. The same threshold was applied to all the
ells of one PCR plate. Measurement results of single PCR wells
ere excluded on the basis of technical reasons in case that (i) the
otal number of accepted droplets was <10,000, (ii) the average ﬂu-
rescence amplitudes of positive or negative droplets were clearly
ifferent from those of the other wells on the plate, or (iii) 5 % of the
ccepted droplets had a ﬂuorescence amplitude signiﬁcantly below
he average amplitude of the negative droplet cluster (i.e. average
 4 × STD). The average number of accepted droplets of the valid
easurement results was around 17,000.
The numbers of positive and accepted droplets were transferred
o an in-house developed spread sheet to calculate the copy number
oncentration in the sample (csample) using Eq. (1) with a droplet
olume set at 0.834 nL [22].
sample = Dfsample × DfPCR ×
(
1
A × Vd
)
×
(
log
(
1 − PA
))(
log
(
1 − 1A
)) (1)
With Dfsample: dilution factor of the DNA sample before adding
to the PCR mix;
DfPCR: dilution factor of the DNA solution in the PCR mix;
A: number of analysed droplets;
P: number of positive droplets;
Vd: droplet volume.
Throughout this manuscript, the term sample copy number
oncentration(csample) is used to describe the copy number concen-
ration of the undiluted sample, while the term PCR copy number
oncentration (cPCR) is used to refer to the copy number concentra-
ion in the PCR mix.
The dMIQE checklist [18] of these ddPCR experiments can be
ound in the Supplementary data Table 3.
. Results
.1. Selectivity
The primers and probes of the BCR-ABL ddPCR method are also
sed in a standardised qPCR method developed during a large
nter-laboratory study and the absence of nonspeciﬁc ampliﬁcation
rtefacts in qPCR has been shown [20,21]. The selectivity of the BCR-
BL ddPCR method was  experimentally assessed by performing 4
eplicate measurements of a matrix blank consisting of 1 × T1E0.01
uffer with the nucleic acid background of the ERM-AD623 sam-
les (i.e. transfer RNA from E. coli) and 4 replicates of a positive
ontrol consisting of an undiluted sample of ERM-AD623a at a PCR
opy number concentration of 54000 cp/L. Results showed a clear
ifference in ﬂuorescence amplitude between the negative droplet
luster (average 1764 and STD 135) and the positive droplet cluster
average 5418 and STD 212). With the threshold placed at the mid-nd Quantiﬁcation 9 (2016) 29–39 31
point between the average ﬂuorescence amplitudes of the positive
and negative droplet cluster, no droplets in matrix blank replicates
were classiﬁed as positive (0/61275) and only 0.057 % (33/57895)
of the droplets in the positive control replicates were classiﬁed as
negative.
3.2. Working range
The working range of the BCR-ABL ddPCR method was  inves-
tigated by measuring one sample of each of the ﬁve lowest
ERM-AD623 concentration levels at different PCR copy number
concentrations: ERM-AD623b was  measured at 5400 cp/L, ERM-
AD623c at 2575 cp/L, ERM-AD623d at 255 cp/L, ERM-AD623e at
26 cp/L and ERM-AD623f at 2.5 cp/L. For each concentration, 8
replicate measurements were performed, and the replicates were
spread over 4–5 cartridges and randomly positioned on the 96-well
PCR plate.
None of the measurement results was rejected based on the
technical reason exclusion criteria described in Section 2.3. The
relative STD of the replicate measurement results was < 5% for the
PCR copy number concentrations between 26 and 5400 cp/L. At
the lowest PCR copy number concentration of 2.5 cp/L, the rel-
ative STD increased to 16.9 % suggesting that this concentration
might be out of the working range. A precise determination of the
lower end of the working range is discussed during the assessment
of the limit of quantiﬁcation (LOQ) of the method in Section 3.6.
The relation between the expected PCR copy number concentra-
tion (cPCR,exp) and the measured PCR copy number concentration
(cPCR,meas) was linear (r2 = 0.9985, see Fig. 1) and the equation of
the regression line was cPCR,meas = 0.8677 × cPCR,exp. This regression
line indicates that cPCR,meas is about 13 % lower than the cPCR,exp sug-
gesting a bias between the certiﬁed copy number concentrations of
ERM-AD623 and the copy number concentrations measured by the
BCR-ABL ddPCR method. A more precise estimate of this bias based
on many measurement results was  obtained during the assessment
of the method accuracy below.
3.3. Accuracy
The ﬁve highest concentration levels of ERM-AD623 were mea-
sured with the BCR-ABL ddPCR method at PCR copy number
concentrations of 250–450 cp/L (for ERM-AD623a, b, c and d)
and 25–35 cp/L (for ERM-AD623e). The samples of ERM-AD623a,
ERM-AD623b and ERM-AD623c were gravimetrically diluted in
T1E0.01 buffer to a nominal concentration between 1000 cp/L and
1800 cp/L before adding to the PCR Mix. The experiments were
performed in 3 runs and each ERM-AD623 concentration level was
measured with 12 replicates in runs 1 and 3, and 16 replicates in
run 2. The replicate measurements within one run were carried
out under repeatability conditions meaning: the same analyst, the
same pre-sample mix, cartridges from the same batch, the same
instruments and randomly positioned on the same 96-well PCR
plate. Between the runs, intermediate precision conditions were
applicable, meaning: 3 different analysts, 2 different droplet gen-
erators, 2 different droplet readers, 2 different types of cartridges, 3
different batches of reagents and 3 different versions of the Quan-
taSoft software. In total, 200 measurement results were obtained,
and only 4 of them were rejected because of technical reasons.
The nested design of this experiment allowed an estimation of
the method repeatability and the run-to-run variation as prescribed
by ISO 5725-3. [23] The results were grouped per run and analysed
with a one-way analysis of variance (ANOVA) test. For each ERM-
AD623 concentration level, the relative repeatability (srepeat,rel) and
32 L. Deprez et al. / Biomolecular Detection and Quantiﬁcation 9 (2016) 29–39
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rig. 1. Linearity of the BCR-ABL ddPCR method when measuring ERM-AD623 samp
he  data points represent the average result for eight replicate measurements, and
he  standard uncertainty associated with the certiﬁed values of the ERM-AD623 sam
he relative run-to-run variation (srun,rel) both expressed as STD
ere calculated using Eqs. (2) and (3), respectively.
repeat,rel =
√
MSwithinrun
c¯sample,meas
(2)
run,rel =
√
MSbetweenrun−MSwithinrun
n¯repli
c¯sample,meas
(3)
With MSwithin run: the within run mean of squares calculated by
one-way ANOVA
MSbetween run: the between run mean of squares calculated by
one-way ANOVA
n¯repli: average number of replicates per run
c¯sample,meas: average measured sample copy number
concentration over all runs.
It should be noted that srepeat,rel and srun,rel are estimates of the
rue STD and are subject to random ﬂuctuations. It can, therefore,
appen that MSbetweenrun is smaller than MSwithinrun and then srun,rel
able 2
esults of the accuracy assessment of the BCR-ABL ddPCR method performed by measuri
CRM csample,cert ± Ucert(cp/L) csample,meas(cp/L) 
AD623a (1.08 ± 0.13) × 106 0.97 × 106
AD623b (1.08 ± 0.11) × 105 0.93 × 105
AD623c (1.03 ± 0.10) × 104 0.94 × 104
AD623d (1.02 ± 0.09) × 103 0.93 × 103
AD623e (1.04 ± 0.10) × 102 0.97 × 102
sample,cert : certiﬁed sample copy number concentration,Ucert : expanded uncertainty of th
umber concentration, biasrel: relative bias between the certiﬁed value and the measured v
elative  standard uncertainty related to the precision, *: MSbetweenrun < MSwithinrun .thin a PCR copy number concentration range of 2.5 cp/L to 5400 cp/L.
ertical error bars represent the associated STD. The horizontal error bars represent
.
cannot be estimated with Eq. (3). In this case, we  considered srun,rel
equal to zero as it is negligible compared to the srepeat,rel .
Based on the srepeat,rel and srun,rel the relative standard uncer-
tainty of the method precision (uprecision,rel) associated with the
average measured sample copy number concentration (c¯sample,meas)
was calculated using Eq. (4).
uprecision,rel =
√
s2
repeat,rel
n¯repli × nrun
+
s2
run,rel
nrun
(4)
With nrun: number of runs, which is 3 in this case
The calculated values for srepeat,rel , srun,rel , and uprecision,rel are
shown in Table 2. The ﬁve values obtained for each parameter
(one per ERM-AD623 concentration level) were combined into one
pooled value by taking the root mean square (RMS, also called
quadratic mean) calculated as the square root of the average of the
squared values. The pooled relative repeatability (srepeat,pooled,rel)
was 6.1 %, the pooled relative run-to-run variation (srun,pooled,rel)
was 2.9 % and the pooled relative standard uncertainty related to
precision (uprecision,pooled,rel) was 1.9 %.
ng the ﬁve highest concentrations levels of ERM-AD623.
biasrel(%) srepeat,rel(%) srun,rel(%) uprecision,rel(%)
−10.2 4.7 1.4 1.1
−13.8 5.6 5.3 3.2
−9.0 4.8 2.7 1.8
−8.5 7.7 0* 1.2
−7.0 7.3 2.0 1.6
e certiﬁed copy number concentration, csample,meas: average measured sample copy
alue, srepeat,rel: relative repeatability, srun,rel: relative run-to-run variation, uprecision,rel:
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The trueness of the BCR-ABL ddPCR method was evaluated by
stimating the relative bias (biasrel) for each ERM-AD623 con-
entration level as the relative difference between the average
easured sample copy number concentration (c¯sample,meas) and the
ertiﬁed sample copy number concentration (csample,cert)(see Eq.
5)).
iasrel =
c¯sample,meas − csample,cert
csample,cert
(5)
The average relative bias (biasrel), calculated as the arithmetic
ean of the ﬁve values for biasrel(one per ERM-AD623 concen-
ration level), was −9.6 %. To evaluate whether or not this biasrel
s signiﬁcant, the uncertainty associated with this bias estimate
as calculated taking into account the uncertainty associated
ith the average measured copy number concentrations (i.e.
precision,pooled,rel) and the relative standard uncertainty associated
ith the certiﬁed copy number concentration of each ERM-AD623
oncentration level (ucert,rel). Both uncertainty contributions were
ombined in the relative uncertainty of the bias estimate (ubias,rel)
sing Eq. (6).
bias,rel =
√√√√√
uprecision,pooled,rel2 +
∑e
i=a
(ucert,rel,i)
2
ncert
(6)
ith ncert : the number of certiﬁed reference materials used in the
ssessment of the bias.The ubias,rel was 5.4 %, and the relative expanded uncertainty of
he bias estimate (Ubias,rel) was calculated to be 10.9 % using Eq. (7).
bias,rel = 2 × ubias,rel (7)
ig. 2. A schematic overview of all factors which may  contribute to the uncertainty of the
alidation study.
primers/probe: concentration primers and probe, Dfsample: dilution factor of sample before 
iluent, Mdil+sample: mass of diluent and sample, Mpremix: mass of pre sample mix, Mmix: mnd Quantiﬁcation 9 (2016) 29–39 33
As the absolute value of the estimated biasrel is smaller than Ubias,rel
this bias cannot be considered signiﬁcant, but there is a strong
indication that the BCR-ABL ddPCR method has the tendency to
measure lower copy number concentrations than the chip-based
dPCR method used for the certiﬁcation of the copy number con-
centration of the ERM-AD623 solutions.
3.4. Measurement uncertainty
Measurement uncertainty may  arise from many sources and a
complete list of all potential sources is a good starting point for a
comprehensive estimate of the overall measurement uncertainty
[24]. Fig. 2 gives a schematic overview of all factors which may
contribute to the uncertainty of the measurement results obtained
with the BCR-ABL ddPCR method as performed here.
The results from the assessment for the method precision
provided an estimate of the contribution of several uncertainty
sources. The uncertainty contributions of the random effects,
including sampling, random variation in the droplet volume,
binominal distribution and the position in the thermocycler, were
included in the srepeat,pooled,rel while the srun,pooled,rel covers the
uncertainty arising from the run-to-run effects such as the type of
cartridges, the reagent batches, the droplet reader/generator and
the analyst.
The tendency to measure with the BCR-ABL ddPCR method
lower copy number concentrations than the certiﬁed copy num-
ber concentrations of the ERM-AD623 samples indicates that some
of the remaining sources also have an important effect on the
measurement result and make a signiﬁcant contribution to the
overall measurement uncertainty. These factors were therefore
investigated in greater detail. The estimation of the uncertainty
 measurement results obtained with BCR-ABL ddPCR method as performed in this
addition to PCR mix, DfPCR: dilution factor of sample in the PCR mix, Mdil: mass of
ass of the PCR mix  with sample, Vd : volume of the droplets
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ontribution of several individual factors was based on previous
nowledge and uncertainty components < 1 % were not considered
s signiﬁcant. These negligible uncertainty sources are the accuracy
f the weighing, the uncertainty associated with density determi-
ation of the pre-sample mix  and the uncertainty related to the
urity and quality of the HPLC-puriﬁed primers and probes [25].
he samples that are intended to be measured with the BCR-ABL
dPCR method are highly puriﬁed solutions of linearized plasmid
NA in a T1E0.01 buffer with a nucleic acid background. As these
olutions are candidate certiﬁed reference materials, the intact-
ess of the DNA molecules and their stability has already been
nvestigated. Due to the particular nature of the samples, the fol-
owing sources of uncertainty were also considered to be negligible:
resence of single-stranded DNA, presence of PCR inhibitors, the
resence of secondary DNA structures, which might disturb the
andom distribution of the target sequence over the droplets, and
he accessibility and intactness of the target sequence.
The droplet volume determines the absolute copy number con-
entration calculated with Eq. (1). We  have used a droplet volume
f 0.834 nL as this volume was previously measured in our labora-
ory using the same equipment, the same type of supermix and the
ame type of samples. The relative standard uncertainty associated
ith the measured droplet volume (uVd , rel)  was 1.8 % [22].
Two sources of measurement uncertainty (i.e. the assay and the
hreshold setting) were investigated in a dedicated study to esti-
ate their contribution to the overall measurement uncertainty.
.4.1. Uncertainty component related to the assay
By measuring the ERM-AD623 samples with another combina-
ion of primers and probe, it has been investigated if the assay itself
as a signiﬁcant contribution to the measurement uncertainty.
herefore, the ﬁve highest concentration levels of ERM-AD623
ere also measured with the ABL ddPCR method. The set-up of the
xperiments was identical to the experiments performed to assess
he accuracy of the BCR-ABL ddPCR method, meaning 3 runs with
ach 12–16 replicates per ERM-AD623 concentration level under
epeatability conditions within the runs and intermediate precision
onditions between the runs. Fourteen of the 200 measurement
esults obtained with the ABL ddPCR method were rejected because
f technical reasons. The results of the ABL and the BCR-ABL assay
ere grouped per assay and per ERM-AD623 concentration level.
or each concentration, the relative STD due to the assay (sassay)
as calculated using one way-ANOVA and Eq. (8).
assay,rel =
√
MSbetweenassay−MSwithinassay
n¯meas,assay
c¯sample,meas
(8)
With MSwithin assay: the mean of square of results obtained with
one assay
MSbetween assay: the mean square between results obtained with
the two assays
n¯meas,assay: the average number of measurements per assay
c¯sample,meas: average measured sample copy number
concentration from both assays
The ﬁve values for sassay (one per ERM-AD623 concentra-
ion level) were pooled by calculating the RMS. The resulting
assay,pooled,rel was 1.0 % indicating that the uncertainty contribution
f the assay can be considered as negligible.
.4.2. Uncertainty related to the threshold setting
The classiﬁcation of the droplets into positive or negative
epends on the ﬂuorescence amplitude of the threshold. For the
xperiments performed here, the threshold was set at the midpoint
etween the average ﬂuorescence amplitude of the positive and
egative droplet cluster. However, other approaches can be used,
nd they may  lead to different measurement results. The variabil-nd Quantiﬁcation 9 (2016) 29–39
ity among the results obtained with different threshold settings is
caused by the presence of droplets with ﬂuorescence amplitude
above the upper boundary of the negative cluster and below the
lower boundary of the positive cluster, the so-called rain droplets.
We deﬁned the boundaries of the negative and positive droplet
cluster as the average amplitude ± 4 × STD as this range would the-
oretically include all droplets of that cluster in case of a normal
distribution of the ﬂuorescence data. It is unclear whether or not the
rain droplets, in reality, contain a copy of the target sequence as we
observed rain droplets in both the matrix blank and the highly pos-
itive control sample. An estimation of the maximum uncertainty
contribution related to the threshold setting can be obtained by
analysing the same measurement data with 3 completely different
approaches to classifying the rain droplets:
• Low threshold placed at the upper boundary of the negative
droplet cluster (all rain droplets are considered positive)
• High threshold placed at the lower boundary of the positive
droplet cluster (all rain droplets are considered negative)
• Rain removal: rain droplets were not considered as accepted
droplets [26]
The impact of small changes in the ratio of positive
droplets/accepted droplets on the measured value depends on the
PCR copy number concentration at which the measurements are
performed: the effect is larger at the lower and the higher end of
the working range. The effect of the threshold setting was  there-
fore investigated at 5 different PCR copy number concentrations.
The data of the experiment performed to determine the work-
ing range (Section 3.2.) were reused for this purpose. The original
results (obtained with a threshold placed at the midpoint) and these
reanalysed results were grouped per replicate measurement. One-
way ANOVA and Eq. (9) were used to calculate the relative STD for
the results obtained with the different threshold settings (sthres,rel)
(see Table 3).
sthres,rel =
√
MSwithinrepli
c¯PCR,meas
(9)
With MSwithin repli: the mean of squares of the results for one
replicate measurement
c¯PCR,meas: the average measured PCR copy number
concentration
These results show that the maximum uncertainty related to
the threshold setting can be considered negligible for measure-
ments performed with the BCR-ABL ddPCR method in the PCR copy
number concentration range between 26 and 2575 cp/L.
3.4.3. Overall measurement uncertainty
The uncertainty contributions found to be signiﬁcant can be
combined into one relative expanded measurement uncertainty
(Umeas,rel) using Eq. (10). This equation can be used to estimate the
Umeas,rel for any measurement result obtained with the BCR-ABL
ddPCR method provided that the measured sample is similar to the
ERM-AD623 samples and that the PCR copy number concentration
is in the range of 25–450 cp/L.
Umeas,rel = 2 ×
√
srepeat,pooled,rel2
nmeas
+ srun,pooled,rel
nrun
2
+ uVd,rel2 + ubias,rel2 (10)
With nmeas: the number of measurements on which the
measurement result is basednrun: the number of runs over which the measurements are
spread
For a measurement result obtained as the average of 4 replicate
measurements performed in a single run the Umeas,rel is 14.2 %.
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Table  3
Results of the experiment to assess the uncertainty contribution of the threshold setting.
cPCR,exp
(cp/L)
Average number
of positive
droplets/measurement
Average number
of negative
droplets/measurement
Average number of rain
droplets/measurement
sthres(%)
5400 18046 414 95.9 3.0
2575  16005 2530 39.0 0.5
255  3488 16248 14.3 0.3
26  397 19457 4.1 0.8
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niﬁcant effect on the obtained measurement results taking into
account the associated measurement uncertainty.
Table 4
Results of the robustness test on the BCR-ABL ddPCR method investigating the
effect of minor deviations in the primers/probe concentrations and annealing
temperature.
Sample Annealing
temperature
(◦C)
Primers/probe
concentration in
PCR mix (nM)
cPCR,meas
average ± STD
(cp/L)
ERM-AD623d 60 300/200 279 ± 5
60  330/220 273 ± 4
60  270/180 285 ± 82.5  38 19708 
PCR,exp: the expected PCR copy number concentration based on the certiﬁed values 
.5. Limit of detection (LOD)
The LOD is deﬁned as the lowest PCR copy number concentra-
ion that can be distinguished from zero with a level of conﬁdence of
5 %. A rough estimate of the LOD of the BCR-ABL ddPCR method
as obtained by measuring one sample of ERM-AD623f in 64
eplicates at a concentration of 0.50 cp/L in the PCR mix. The
eplicate measurements were performed under repeatability con-
itions. Four of the measurement results were rejected because of
echnical reasons and all of the 60 valid replicate measurements
ave a positive result. The average measured PCR copy number
oncentration was 0.56 cp/L with a relative STD of 34.4 %. These
esults indicate that the LOD of this method is < 0.50 cp/L in the
CR mix.
.6. Limit of quantiﬁcation (LOQ)
The LOQ is deﬁned as the lowest PCR copy number concen-
ration for which the method provides results with an acceptable
ncertainty. So, the LOQ of a method depends on the level of
ncertainty considered acceptable given the intended use of the
ethod. For the purpose of certifying the absolute copy number
oncentration of puriﬁed plasmid solutions, we  considered the
aximum acceptable expanded measurement uncertainty to be
0 % for a measurement result obtained as an average value of
our replicate measurements. This maximum acceptable expanded
easurement uncertainty is 2 times larger than the expanded
ncertainty obtained for measurements with the PCR copy number
oncentration range of 25–450 cp/L, but at very low concentra-
ions, stochastic effects will have a major impact on the method
epeatability and therefore on the overall measurement uncer-
ainty.
Samples of ERM-AD623f were measured with the BCR-ABL
dPCR method at a PCR copy number concentration of 3.50 cp/L.
easurements were spread over two runs, and one run con-
isted of 12 replicate measurements. Within one run repeatability
onditions were applicable and between the runs intermediation
recision conditions were used as described before.
In total, 24 measurement results were obtained, and only one
as rejected because of technical reasons. The average measured
CR copy number concentration was 3.35 cp/L, and the relative
ias between the measured value and the certiﬁed value was −
.3 % (according to Eq. (5)). The results were grouped per run
nd analysed with ANOVA to estimate the measurement preci-
ion of the BCR-ABL ddPCR method. Using Eqs. (2) and (3), the
elative repeatability (srepeat,rel) was calculated to be 17.0 % and
he run-to-run variation (srun,rel) was considered negligible as
Sbetweenrun < MSwithinrun.The relative standard uncertainty related
o precision (uprecision,rel) was estimated to be 5.0 % with Eq. (4). The
xpanded uncertainty associated with the bias estimate (Ubias,rel)
as 18.0 % (according to Eq. (7)), indicating that the relative bias of
4.3 % is not signiﬁcant.
To calculate the overall measurement uncertainty for an average
easurement result of 4 replicates one has to add the estimate of3.6 7.2
-AD623, sthres,rel: relative standard deviation associated with the threshold setting
the uncertainty contribution from the threshold setting (sthreshold)
to Eq. (10) as this uncertainty is not negligible at the limits of the
working range (see Table 3).
The overall measurement uncertainty was calculated to be
28.9 % for an average measurement result from 4 replicates indicat-
ing that a PCR copy number concentration of 3.50 cp/L is a good
estimate of the LOQ for the intended use of the method.
3.7. Robustness (ruggedness)
During the robustness test, the effect of small deviations in rel-
evant method parameters on the method performance and the
measurement results are investigated. For the BCR-ABL ddPCR
method, relevant method parameters that are likely to inﬂuence
the method outcome are the primer and probe concentrations and
the annealing temperature.
The effect of minor variations in the primer and probe con-
centrations was  investigated by performing the BCR-ABL ddPCR
method with three different concentrations: the optimal concen-
trations as described in Supplementary data Table 1, concentrations
that are 10 % lower and concentrations that are 10 % higher than
the optimal concentrations. For each primer and probe concen-
tration level, 10 replicate measurements were performed for one
sample of ERM-AD623d at an expected PCR copy number concen-
tration of 310 cp/L. Three measurement results were rejected
because of technical reasons. To test the effect of small deviations in
the annealing temperature, the BCR-ABL ddPCR was  performed at
three different annealing temperatures: 60 ◦C (the optimal anneal-
ing temperature) 61 ◦C and 59 ◦C. For each annealing temperature,
14 replicate measurements of one ERM-AD623c sample were done
at an expected PCR concentration of 3200 cp/L. One measurement
result was rejected because of technical reasons.
The results of the robustness assessment are shown in Table 4.
They indicate that minor deviations of the optimal primers/probe
concentration and the annealing temperature do not have a sig-ERM-AD623c 59 300/200 2946 ± 54
60  300/200 2954 ± 35
61  300/200 2948 ± 68
cPCR,meas: the average measured PCR copy number concentration.
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. Discussion
The approaches used in this validation of the BCR-ABL ddPCR
ethod are based on the recommendations described in various
uidance documents on method validation and estimation of the
easurement uncertainty [15,16,24] and the study design was
dapted to the intended use of the method and the availability
f certiﬁed reference materials. It should also be noted that this
ethod validation covers only the performance parameters of the
PCR method itself. There are several additional factors inﬂuencing
he value of dPCR measurement results for diagnostics and other
ecisions such as the biological variability of the target sequence,
he sample source, the sample preparation and the sample storage
27,28].
The method validation study described here may  not be suitable
or each dPCR method, however, there are some general consider-
tions which are applicable for any dPCR method validation.
.1. Selectivity
Analytical selectivity is deﬁned as the degree to which the
ethod can quantify the particular analyte accurately without the
nterference of other substances which could be present in the sam-
les. The interfering substances may  cause a bias by increasing or
ecreasing the signal attributed to the analyte. For dPCR, selectivity
an be translated into the degree to which partitions classiﬁed as
ositive contain one or more copies of the target sequence, and the
egative partitions contain no copy of the target sequence. Interfer-
nces could cause non-speciﬁc ampliﬁcation or PCR inhibition. The
evelopment of a dPCR method with a good selectivity requires a
onscious design of the PCR assay including a blast search for sim-
lar sequences and a thorough optimisation of the primer/probe
oncentrations and the annealing temperature. During method
alidation, the selectivity should be experimentally assessed by
easuring the target sequence in samples to which interferences
ossibly present in real-life samples are deliberately introduced
15]. Examples of these interfering substances are highly similar
equences or organic substances such as phenol or ethanol intro-
uced during the nucleic acid extraction. Analysis of a matrix blank,
.e. a sample with the same background and interfering substances
s a real sample but without the target sequence can be used to
dentify interfering substances which lead to false positive parti-
ions. A positive control sample with a high concentration of the
arget sequence can be analysed to identify interfering substances
eading to false negative partitions. These positive control samples
re preferably routine test samples, but in case that these are not
vailable, spiked samples, in which the target sequence is added at
igh concentration, could be used as an alternative.
.2. Working range
Digital PCR systems can detect a wide range of copy number
oncentrations ranging from one single copy to several hundreds
r thousands of copies depending on the number of analysed parti-
ions. However, the precision (and, therefore, also the reliability) of
easurement results is not constant across this whole range due to
tochastic effects which have an important inﬂuence at the lower
nd upper limit of the range [5,29]. Stochastic effects mainly play
 role during two steps of the dPCR measurement procedure: the
ampling of the DNA solution added to the PCR mix  and the dis-
ribution of the target sequence over the analysed partitions. Fig. 3
hows the relationship between the theoretical relative STD caused
y these stochastic effects and the PCR copy number concentration
or the ddPCR system.nd Quantiﬁcation 9 (2016) 29–39
4.3. Measurement precision
Precision is a measure of the variability in independent mea-
surement results obtained for the same sample under stipulated
conditions. Depending on the stipulated conditions, measurement
precision can be divided into method repeatability, intermediate
precision and reproducibility. Within the frame of a single labo-
ratory validation, both the method repeatability and intermediate
precision need to be investigated. Repeatability is a parameter for
the variability in results of measurements performed by a single
analyst using the same equipment and reagents during a short
period of time. Intermediate precision gives an estimate of the vari-
ation in results from measurements made under conditions which
are more variable than repeatability conditions. Ideally, the effect
of all sources of variation that could occur during routine use in a
single laboratory should be investigated. The assessment of method
reproducibility requires measurement results obtained by different
laboratories. This information is quite valuable but not mandatory
in case of a single laboratory method validation [15].
4.4. Trueness
Measurement trueness is an expression of how close the mean
of an inﬁnite number (i.e. a large number in reality) of results pro-
duced by the method comes to a reference value. There are three
general approaches to obtain a suitable reference value: i) use of
certiﬁed reference materials, ii) recovery experiments using spiked
samples, and iii) comparison with results obtained from another
method. For the ﬁrst option, it is important that the chosen cer-
tiﬁed reference material is appropriate, meaning the same or a
very similar matrix and a target sequence copy number concen-
tration within the same range as the routine samples [15]. In case
no suitable certiﬁed reference material is available, it is possible to
use spiked samples by adding a known copy number concentra-
tion of the target sequence in a matrix blank. However, one should
note that these samples could stipulate an over-optimistic trueness
assessment as the spiked target sequences might be easier accessi-
ble for ampliﬁcation or more intact than the normal target sequence
in a routine sample. It is also possible to assess the trueness by
comparing results from the candidate method with those obtained
from an alternative validated method. There are only a few methods
that can verify the absolute copy number concentration measured
by dPCR. One option is to compare with the results obtained with
UV spectrophotometric methods that rely on the molar absorbance
of the nucleic acids present in the solution [11,30]. However, this
is only possible for a limited number of sample types which are
pure solutions of a single well-deﬁned nucleic acid sequence. One
additional drawback is the need for a series of carefully prepared
gravimetrical dilutions as the optimal concentration range for UV
spectrometric methods is usually several magnitudes larger than
the optimal concentration range for dPCR measurements. A com-
parison with other sequence-speciﬁc quantiﬁcation methods is also
complicated. Quantitative real-time PCR results rely on the copy
number concentration assigned to the calibrant. The use of another
dPCR system, preferably one that uses a different technique to par-
tition the PCR mix  could be an option. In any case, the alternative
method has to be validated and its measurement uncertainty must
be correctly estimated.
4.5. Measurement uncertainty
Measurement uncertainty may  arise from many sources, and
these sources of uncertainty can be divided into ﬁve different lev-
els: random effects, run-to-run effects, laboratory bias, method bias
and matrix variation effects [16]. The uncertainty contribution of
the random effects and run speciﬁc effects are assessed as method
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Fig. 3. The relative STD caused by stochastic effects in relation to the PCR copy number concentration for the ddPCR system.
The  relative STD resulting from stochastic effects (sstochastic effects,rel) consists of two  components: the relative STD caused by the stochastic effects when sampling the DNA
solution added to the PCR mix  (ssampling,rel) and the relative standard deviation caused by the stochastic effects of the distribution of the target sequence over the analysed
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escribed in [29]. Tsampled: the expected number of target sequences sampled, TA: th
roplets, P: number of positive droplets.
epeatability and run-to-run variation, respectively. The laboratory
ias can be estimated from the method reproducibility obtained in
arge collaborative trails. In case of single-laboratory validation a
rueness test can be used to assess the combination of the labora-
ory and method bias [16].
Typically, the individual sources of uncertainty are only investi-
ated when they might be signiﬁcant compared to the uncertainty
ssociated with the precision or the bias estimate of the method.
ncertainty contributions that are smaller than 1/3 of the largest
ncertainty component will have no signiﬁcant effect on the over-
ll measurement uncertainty and can be considered negligible [24].
wo sources of measurement uncertainty that are speciﬁc for dPCR
easurements are discussed in greater detail in the following: the
ncertainty contribution of the threshold setting and the uncer-
ainty contribution of the assigned partition volume.
The importance of the uncertainty contribution of the threshold
etting is determined by the number of partitions with inter-
ediate ﬂuorescent amplitude (meaning between the ﬂuorescent
mplitude of the negative and the positive partitions). The causes
f this intermediate ﬂuorescent amplitude are multiple, includ-
ng abnormal sized partitions, presence of PCR inhibitors, reduced
ccessibility of the target sequence, non-speciﬁc ampliﬁcation and
ncomplete mixing of PCR reagents. During the method develop-
ent, efforts should be made to reduce the amount of partitions
ith intermediate ﬂuorescent amplitude to a minimum by a good
election of the primer and probe sequences, careful titration oftion, and the estimation of sdistribution,rel is based on the binominal distribution as
ected number of target sequences in the analysed droplets, A: number of analysed
primer and probe concentrations and optimisation of the PCR con-
ditions. Improving the quality of the analysed samples might also
have an effect. During the method validation, the amount of parti-
tions with intermediate ﬂuorescent amplitude should be quantiﬁed
both in samples with a high and a low copy number concentration
of the target sequence to get information about their proportion
compared to the positive and negative partitions, respectively. Sup-
plementary data Fig. 1 shows the results of a theoretical simulation
for the ddPCR system in which the maximum uncertainty related
to the threshold setting is calculated for different proportions of
rain droplets. In case of very low proportions of rain droplets (e.g.
0.01 % of the negative droplets or 0.1 % of the positive droplets)
the maximum uncertainty related to the threshold setting can be
considered negligible compared to the other uncertainty contri-
butions. However, for ddPCR methods with higher proportions of
rain droplets the threshold-related uncertainty might become a sig-
niﬁcant contributor to the overall measurement uncertainty. The
uncertainty related to the threshold setting is not constant over
the whole working range of a dPCR method and will be larger at
the limits.
The uncertainty of the partition volume contributes to the
overall measurement uncertainty of a dPCR measurement when
absolute copy number concentrations are measured. The manufac-
turer often provides the partition volume of a dPCR system without
any information about the associated uncertainty. Results of inde-
pendent attempts to verify the partition volume and to estimate
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he associated uncertainty have been described for different dPCR
ystems [22,29,31,32]. The obtained results do not always agree,
nd more research is still needed. The uncertainty on the partition
olume is probably one of the major reasons of the measurement
ias between different dPCR systems as also observed during the
ethod validation presented above. In the case of the ddPCR sys-
em, the volume of the droplets could be inﬂuenced by the type
f samples, the cartridges and the instruments, but especially by
he type of supermix, which plays a major role [32]. Therefore it is
mportant to use the droplet volume which is the most appropri-
te for the speciﬁc ddPCR method and to include the uncertainty
ssociated with this droplet volume in the overall measurement
ncertainty budget.
.6. Limit of detection and quantiﬁcation
Many of the guidance documents on method validation describe
tatistical approaches for the determination of LOD and LOQ that
epend on the assumption of normal distribution [16]. The mea-
urement principle of the dPCR makes it possible to detect up to
ne copy of a target sequence and the Poison distribution is appli-
able at these very low copy number concentrations. Therefore it
s more reasonable to assess the LOD and LOQ by performing many
eplicate measurements at very low copy number concentrations.
he assessment should start by clearly deﬁning the level of con-
dence appropriate for the intended use of the method. In case
hat the copy number concentration of the target sequence in the
outine samples will be always well above the LOD, it is sufﬁcient
o have a rough estimate of the LOD as done in the method vali-
ation presented above. When performing an experiment with 60
eplicate measurements exactly at the LOD there would be on aver-
ge 3 negative measurement results, as this represents 5 % of the
ases. If all of the 60 replicate measurements performed at a certain
CR copy number concentration are positive, it can be reasonably
ssumed that this concentration is above the LOD of the method.
ore accurate estimates of the LOD are required for dPCR meth-
ds that are intended to be used to measure samples in which the
arget sequence could be absent, and this absence would lead to rel-
vant decisions. In this case, negative measurement results should
e reported as copy number concentration < LOD with a speciﬁed
onﬁdence level.
The LOD and LOQ of a dPCR method depend on the num-
er of analysed partitions and the total volume of the analysed
artitions. In case of the ddPCR system the number of analysed
artitions varies. The impact on the LOD and LOQ can be illustrated
y calculating the theoretical minimum LOD based on the Poisson
istribution, both at the level of sampling and the distribution of
he target sequence over the droplets. In the case of 15 000 ana-
ysed droplets with a droplet volume of 0.834 nL, the minimum
heoretical LOD will be 0.32 cp/L in the PCR mix, as 5 % of the
easurements at this level will not have a single copy of the target
equence in the analysed droplets. In case that the number of ana-
ysed droplets is 10 000, the minimum theoretical LOD will increase
o 0.44 cp/L. Careful manipulation of the droplets and rejection of
easurement results with a low number of accepted droplets (as
one in this study by applying the technical reason exclusion crite-
ia mentioned in Section 2.3) are therefore required to guarantee a
ertain LOD and LOQ.
.7. Robustness
The robustness of a method is tested by making small but delib-
rate changes to the method variables and studying the effect on
he method performance [16]. The investigated method variables
hould be expected to have an important inﬂuence on the method
erformance, i.e. the measurement result, and the size of the delib-
[nd Quantiﬁcation 9 (2016) 29–39
erate changes should be relevant for the routine use of the method.
For a dPCR method, the effects of small changes in the primer and
probe concentrations and the annealing temperature are useful to
investigate as they can occur due to random pipetting errors and
temperature ﬂuctuations in the thermocycler.
5. Conclusion
The method validation described here can be used as an example
for other single laboratory validations of dPCR methods. However,
the extensiveness of a method validation should always depend
on the intended use of the method and on the acceptable level of
measurement uncertainty. The experiments should be conducted
in a manner which provides a realistic view of all the factors pos-
sibly affecting the measurement result during routine use of the
method, as well as covering the concentration ranges and sample
types within the scope of the method [24]. The most challenging
part of the validation of dPCR methods is probably the veriﬁcation
of the trueness, as representative samples with a reference value
are often difﬁcult to ﬁnd. The development of suitable certiﬁed ref-
erence materials will diminish this problem and can promote the
transition of newly developed dPCR methods into reliable analytical
methods suitable for diagnostic or other routine testing purposes.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.bdq.2016.08.002.
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